Post by account_disabled on Mar 9, 2024 5:22:07 GMT
With the pharmaceutical industry “we are trying to build a relationship of trust, but with caution. “We have to trust” that business owners are willing to obey the legal framework without discussions and put an end to attitudes that in the first months of this administration revealed practices far from the commitment to health protection and prevention of health risks, José expressed. Alonso Novelo Baeza, head of the Federal Commission for the Protection against Health Risks (Cofepris).
He recognized that the sector is strategic. In Chile Mobile Number List all countries the pharmaceutical industry is, so as not to depend on the outside, and "we must support it", but under a scheme of balance with health.
In Mexico this circumstance has not occurred, and it is evident in the difficulties in obtaining medicines that are taken over by monopolies. In fact, he said, the laboratories have caused the biggest problems in these first months of government. “We trust that all this will decrease and we will fulfill the task of having an exemplary pharmaceutical industry for the world.”
Novelo Baeza is the first commissioner with medical training. He is a specialist in pediatrics, defines himself as incorruptible and responds to those who criticize his lack of experience in health regulation: “A curriculum is not a guarantee of anything”; He asks that he be judged by his performance, not a priori,” because “that is disqualifying.”
In an interview, his first with a printed media, he commented on the actions he is carrying out to dismantle corruption in Cofepris. One, with authorized third parties, was created in the last administration, with the argument of correcting the lack of capacity to quickly resolve registration procedures for medicines, medical devices or advertising.
There are irregularities and revolving doors: “Personnel from here went to create their companies from authorized third parties, which lends itself to suspicion” and he emphasized: “There will be no facilities for business and corruption.”
The official also commented on his vision on the regulation of cannabis. He said the next regulation will focus on possible therapeutic uses of some plant derivatives and scientific research. Nothing else.
–Has the activity of Cofepris been regularized in the resolution of procedures, how is it going with the delay?
–We found pending procedures since 2006, around 22 thousand, about which no one complained before, as if they did not exist. Suddenly they demand that we attend to them immediately when it comes to incomplete files, in disarray. That complicates the operation of Cofepris. Even so, half of them have been resolved and at the same time we receive 850 new ones every day, of which between 85 and 90 percent are from registrations of medicines, devices and pesticides.
He recognized that the sector is strategic. In Chile Mobile Number List all countries the pharmaceutical industry is, so as not to depend on the outside, and "we must support it", but under a scheme of balance with health.
In Mexico this circumstance has not occurred, and it is evident in the difficulties in obtaining medicines that are taken over by monopolies. In fact, he said, the laboratories have caused the biggest problems in these first months of government. “We trust that all this will decrease and we will fulfill the task of having an exemplary pharmaceutical industry for the world.”
Novelo Baeza is the first commissioner with medical training. He is a specialist in pediatrics, defines himself as incorruptible and responds to those who criticize his lack of experience in health regulation: “A curriculum is not a guarantee of anything”; He asks that he be judged by his performance, not a priori,” because “that is disqualifying.”
In an interview, his first with a printed media, he commented on the actions he is carrying out to dismantle corruption in Cofepris. One, with authorized third parties, was created in the last administration, with the argument of correcting the lack of capacity to quickly resolve registration procedures for medicines, medical devices or advertising.
There are irregularities and revolving doors: “Personnel from here went to create their companies from authorized third parties, which lends itself to suspicion” and he emphasized: “There will be no facilities for business and corruption.”
The official also commented on his vision on the regulation of cannabis. He said the next regulation will focus on possible therapeutic uses of some plant derivatives and scientific research. Nothing else.
–Has the activity of Cofepris been regularized in the resolution of procedures, how is it going with the delay?
–We found pending procedures since 2006, around 22 thousand, about which no one complained before, as if they did not exist. Suddenly they demand that we attend to them immediately when it comes to incomplete files, in disarray. That complicates the operation of Cofepris. Even so, half of them have been resolved and at the same time we receive 850 new ones every day, of which between 85 and 90 percent are from registrations of medicines, devices and pesticides.